Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company that engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. The Company is developing single and combination therapies to treat cancers.

To strengthen our highly motivated team in Heidelberg, Germany, we are looking for a

Senior Preclinical Scientist (f/m/d)

(Reference No. R05)

to support all preclinical development of novel biologics in immuno-oncology.

Apply now


  • Drive preclinical development of Affimed´s antibody candidates in a self-reliant and independent manner.
  • Design, organize and monitor in vivo studies (Pharmacodynamics, Pharmacokinetics and Toxicology) in close liaison with contract research organizations (CROs).
  • Develop and validate bioassays in cooperation with CROs.
  • Perform data analysis and evaluate experimental results, document according to industry standards, report to internal and external stakeholders.
  • Write and review project plans and scientific reports (according to GXP standards).
  • Work in close collaboration within cross-functional teams and external partners.


  • Degree in Life Sciences with at least 5 years industrial experience in the described fields.
  • Demonstrated knowledge of biologics drug development.
  • Ability to conduct multiple projects delivering agreed milestones and adhering to timelines.
  • The position requires excellent communication skills and fluency in English.


The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary and collegial team.

For any queries, please contact Susanne Hering (Tel: 06221 6743 675, e-mail:

October 2019

Your application

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.